Registered number
14696691
ALIYAH PHARMS LTD
Filleted Accounts
31 March 2026

ALIYAH PHARMS LTD
Registered number: | 14696691
Balance Sheet
as at 31 March 2026
Notes |  |  | 2026 |  |  | 2025
£ | £
Fixed assets
Tangible assets | 3 |  |  | 840 |  |  | 960
Current assets
Debtors | 4 |  | 3,276 |  |  | -
Cash at bank and in hand |  |  | 6,791 |  |  | 5,891
|  |  | 10,067 |  |  | 5,891
Creditors: amounts falling due within one year | 5 |  | (2,223) |  |  | (2,902)
Net current assets |  |  |  | 7,844 |  |  | 2,989
Total assets less current liabilities |  |  |  | 8,684 |  |  | 3,949
Creditors: amounts falling due after more than one year | 6 |  |  | (2,519) |  |  | (2,094)
Net assets |  |  |  | 6,165 |  |  | 1,855
Capital and reserves
Called up share capital |  |  |  | 100 |  |  | 100
Profit and loss account |  |  |  | 6,065 |  |  | 1,755
Shareholders' funds |  |  |  | 6,165 |  |  | 1,855
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
ALIYAH AUYUB SIDAT
Director
Approved by the board on 16 April 2026

ALIYAH PHARMS LTD
Notes to the Accounts
for the year ended 31 March 2026
1 | Accounting policies
| Basis of preparation
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
| Turnover
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
| Tangible fixed assets
| Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
| Plant and machinery | over 10 years
| Debtors
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
| Creditors
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 | Employees | 2026 |  | 2025
Number | Number
| Average number of persons employed by the company | 1 |  | 1
3 | Tangible fixed assets
|  |  |  |  |  |  |  | Plant and machinery
£
| Cost
| At 1 April 2025 | 1,200
| At 31 March 2026 | 1,200
| Depreciation
| At 1 April 2025 | 240
| Charge for the year | 120
| At 31 March 2026 | 360
| Net book value
| At 31 March 2026 | 840
| At 31 March 2025 | 960
4 | Debtors | 2026 |  | 2025
£ | £
| Trade debtors | 3,276 |  | -
5 | Creditors: amounts falling due within one year | 2026 |  | 2025
£ | £
| Taxation and social security costs | 1,551 |  | 740
| Other creditors | 672 |  | 2,162
|  |  |  |  |  | 2,223 |  | 2,902
6 | Creditors: amounts falling due after one year | 2026 |  | 2025
£ | £
| Directors Loan | 2,519 |  | 2,094
7 | Controlling party
| The company is under the ultimate control of the director by virtue of them owning the fully issued share capital.
8 | Other information
| ALIYAH PHARMS LTD is a private company limited by shares and incorporated in England. Its registered office is:
| 39 HARTLEY STREET
| DEWSBURY
| WEST YORKSHIRE
| WF13 2BQ

ALIYAH PHARMS LTD 14696691 false 2025-04-01 2026-03-31 2026-03-31 VT Final Accounts February 2026 ALIYAH AUYUB SIDAT No description of principal activity 14696691 2024-04-01 2025-03-31 14696691 core:WithinOneYear 2025-03-31 14696691 core:AfterOneYear 2025-03-31 14696691 core:ShareCapital 2025-03-31 14696691 core:RetainedEarningsAccumulatedLosses 2025-03-31 14696691 2025-04-01 2026-03-31 14696691 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14696691 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 14696691 bus:Director40 2025-04-01 2026-03-31 14696691 1 2025-04-01 2026-03-31 14696691 2 2025-04-01 2026-03-31 14696691 core:PlantMachinery 2025-04-01 2026-03-31 14696691 countries:England 2025-04-01 2026-03-31 14696691 bus:FRS102 2025-04-01 2026-03-31 14696691 bus:FilletedAccounts 2025-04-01 2026-03-31 14696691 2026-03-31 14696691 core:WithinOneYear 2026-03-31 14696691 core:AfterOneYear 2026-03-31 14696691 core:ShareCapital 2026-03-31 14696691 core:RetainedEarningsAccumulatedLosses 2026-03-31 14696691 core:PlantMachinery 2026-03-31 14696691 2025-03-31 14696691 core:PlantMachinery 2025-03-31 iso4217:GBP xbrli:pure